Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component.

[1]  E. Wouters,et al.  Current status of research on osteoporosis in COPD: a systematic review , 2009, European Respiratory Journal.

[2]  M. Boyanov.  Estimation of lumbar spine bone mineral density by dual-energy X-ray absorptiometry: standard anteroposterior scans vs sub-regional analyses of whole-body scans. , 2008, The British journal of radiology.

[3]  Martijn A Spruit,et al.  Integration of pulmonary rehabilitation in COPD , 2008, The Lancet.

[4]  O. Johnell,et al.  FRAX™ and the assessment of fracture probability in men and women from the UK , 2008, Osteoporosis International.

[5]  Laura Ray,et al.  Development and Internal Validation of the Male Osteoporosis Risk Estimation Score , 2007, The Annals of Family Medicine.

[6]  Rollin M. Wright.  Use of osteoporosis medications in older nursing facility residents. , 2007, Journal of the American Medical Directors Association.

[7]  I. Reid,et al.  Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? , 2007, Bone.

[8]  J. Hirdes,et al.  Factors associated with pharmacologic treatment of osteoporosis in an older home care population. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  P. Miller,et al.  A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. , 2007, Clinical therapeutics.

[10]  J. Cauley,et al.  Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. , 2007, Archives of internal medicine.

[11]  Peter H Edwards,et al.  Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[12]  E Lespessailles,et al.  Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture. , 2007, Bone.

[13]  U. Gruntmanis.  Male Osteoporosis: Deadly, but Ignored , 2007, The American journal of the medical sciences.

[14]  L. Nesti,et al.  Missed Opportunities in Patients with Osteoporosis and Distal Radius Fractures , 2007, Clinical orthopaedics and related research.

[15]  A. Vrieze,et al.  Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass , 2007, Osteoporosis International.

[16]  L. Melton,et al.  Impact of increased overweight on the projected prevalence of osteoporosis in older women , 2007, Osteoporosis International.

[17]  Thierry Troosters,et al.  American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. , 2006, American journal of respiratory and critical care medicine.

[18]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[19]  I. Reid.  Obesity and osteoporosis. , 2006, Annales d'endocrinologie.

[20]  B. Nordestgaard,et al.  Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. , 2006, American journal of respiratory and critical care medicine.

[21]  E. Wouters,et al.  Body composition and mortality in chronic obstructive pulmonary disease. , 2005, The American journal of clinical nutrition.

[22]  C. Cooper,et al.  Severity of obstructive airway disease and risk of osteoporotic fracture , 2005, European Respiratory Journal.

[23]  Thierry Troosters,et al.  Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[24]  Y. Khang,et al.  Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis , 2005, Osteoporosis International.

[25]  A. Agustí.  Systemic effects of chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.

[26]  A. Ionescu,et al.  Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[27]  A. Hofman,et al.  HMG‐CoA Reductase Inhibitors and the Risk of Vertebral Fracture , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  G. Colice,et al.  Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases. , 2004, Chest.

[29]  J. Pasco,et al.  β‐Adrenergic Blockers Reduce the Risk of Fracture Partly by Increasing Bone Mineral Density: Geelong Osteoporosis Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[31]  J. Vestbo,et al.  Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective , 2003, European Respiratory Journal.

[32]  E. Wouters.  Introduction: systemic effects in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[33]  A. Hofman,et al.  Thiazide Diuretics and the Risk for Hip Fracture , 2003, Annals of Internal Medicine.

[34]  D. Sin,et al.  The risk of osteoporosis in Caucasian men and women with obstructive airways disease. , 2003, The American journal of medicine.

[35]  O. Johnell,et al.  Is there an association between inhaled corticosteroids and bone density in postmenopausal women? , 2003, The Journal of allergy and clinical immunology.

[36]  P. Dekhuijzen,et al.  Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens. , 2002, Chest.

[37]  K. Lau,et al.  Bone Loss in Patients with Untreated Chronic Obstructive Pulmonary Disease Is Mediated by an Increase in Bone Resorption Associated with Hypercapnia , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  G. Fitzmaurice,et al.  Effects of inhaled glucocorticoids on bone density in premenopausal women. , 2001, The New England journal of medicine.

[39]  C. Wong.  Inhaled corticosteroid use and bone mineral density in patients with asthma , 2001 .

[40]  J. Connett,et al.  Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[41]  R. Pistelli,et al.  Correlates of osteoporosis in chronic obstructive pulmonary disease. , 2000, Respiratory medicine.

[42]  E. E. Hajcsar,et al.  Investigation and treatment of osteoporosis in patients with fragility fractures. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[43]  M. Goldstein,et al.  Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. , 1999, Chest.

[44]  J. Rubin,et al.  Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. , 1999, Chest.

[45]  E. Wouters,et al.  Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. , 1999, Clinical nutrition.

[46]  D. Postma,et al.  Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking , 1999 .

[47]  D. Kellerman,et al.  Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. , 1999, The Journal of allergy and clinical immunology.

[48]  D. Postma,et al.  Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. , 1999, The New England journal of medicine.

[49]  E. Wouters,et al.  Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. , 1998, American Journal of Clinical Nutrition.

[50]  E. Wouters,et al.  Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. , 1997, The European respiratory journal.

[51]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[52]  F. Kaplan,et al.  Prevention and management of osteoporosis. , 1995, Clinical symposia.

[53]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.